NBY - NovaBay Pharmaceuticals, Inc.

0.58
0.010   1.690%

Share volume: 12,273
Last Updated: 04-25-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$0.57
0.01
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 25%
Dept financing 24%
Liquidity 75%
Performance 35%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.35%
1 Month
-4.92%
3 Months
-13.63%
6 Months
5.38%
1 Year
-78.99%
2 Year
-57.51%
Key data
Stock price
$0.58
P/E Ratio 
0.00
DAY RANGE
$0.57 - $0.59
EPS 
-$0.36
52 WEEK RANGE
$0.36 - $9.08
52 WEEK CHANGE
-$80.00
MARKET CAP 
3.367 M
YIELD 
N/A
SHARES OUTSTANDING 
4.886 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
2.69
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$36,774
AVERAGE 30 VOLUME 
$65,141
Company detail
CEO: Justin M. Hall
Region: US
Website: novabay.com
Employees: 30
IPO year: 2007
Issue type: Common Stock
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials from skin around the eye, such as the eyelid. The company also provides dermatological solutions for acne, skin care, and skin care products under the DERMAdoctor brand.

Recent news
loading